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Abstract Different frailty definitions are suitable for
different purposes. When investigating its key multidi-
mensional predictors and effects, narrower definitions of
frailty that exclude these elements may be more desir-
able. For this purpose, candidate physical frailty speci-
fications are constructed and then evaluated on their
construct and concurrent validity. For 4638 participants
aged 65 to 89 years from wave 2 (2004) of the English
Longitudinal Study of Ageing, confirmatory factor anal-
ysis is performed to create physical frailty specifications
with four indicators (slowness, weakness, exhaustion,
and weight loss) and with three indicators (slowness,
weakness, and either exhaustion or weight loss). Using
derived factor scores, their convergent, discriminant,
and concurrent validity are compared. For specifications
with four indicators and with three indicators including
exhaustion, slowness contributes dominantly to the
physical frailty factor. However, with three indicators
including weight loss, weakness contributes most.
Where represented, weight loss only contributes mini-
mally. Higher factor scores are significantly associated
with chronic diseases, functional impairment, and poor
self-rated health, although less so for the third specifi-
cation. Factor scores for the first two specifications have
low correlation with psychological and social frailty
while those for the third have negligible correlation.
Factor scores increase with higher Frailty Index al-
though again less so for the third specification. Minor
differences are seen across gender. On account of their
convergent, discriminatory, and concurrent validity,
physical frailty specifications with four indicators and
with three indicators including exhaustion hold promise
for use in investigation of frailty pathways involving
multidimensional predictors and effects.
Keywords Frailty . Specification . Aged . Frailty
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Introduction
Frailty is widely regarded as the multidimensional loss
of an individual’s reserves which results in vulnerability
to developing adverse health-related outcomes
(Espinoza 2005; Lally 2007; Pel-Littel 2009). It is con-
ceptualized as the transitional state between robustness
and functional decline (Lang 2009). The estimated prev-
alence of frailty is about 10 % among people aged
65 years living in the community (Collard 2012). Be-
yond mere numbers of affected people in any
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population, frailty is unfortunately associated with in-
creased risk of death, disability, falls, hospitalization,
and institutionalization (Daniels 2012; Ensrud 2009;
Ensrud 2008; Jones 2005; Kiely 2009; Pilotto 2012;
Woo 2012). Consequently, frailty plays a central role
in determining the well-being of older people and has
major public health importance (Woo 2006).
Over the past decade, the wide array of frailty instru-
ments available (Pialoux 2012) attest to the absence of a
universally accepted concept. Nevertheless, recent ef-
forts to forge consensus among international experts
have achieved some degree of agreement on suitable
instruments for the recognition of frailty in older persons
(Morley 2013). These instruments reflect different albeit
overlapping concepts. Among them, two have gained
greater prominence. The Cardiovascular Health Study
(CHS) frailty phenotype is probably the most widely
adopted. It conceptualizes frailty as a geriatric syndrome
resulting from decline in multiple physiologic systems
and is operationalized by requiring presence of at least
three of its five components: shrinking (unintentional
weight loss), weakness (low hand grip strength), poor
endurance and energy (self-reported exhaustion), slow-
ness (slow walking speed), and low physical activity
level (based on self-report) (Fried 2001). The Frailty
Index (FI) is possibly the second most widely applied
instrument and is based on a deficit accumulation ap-
proach (Rockwood 2007b; Rockwood 2004). A count is
taken of deficits which are a collection of symptoms,
signs, diseases, disabilities, or test abnormalities. Select-
ed deficits should be associated with poorer health sta-
tus, should increase with age but not saturate too early,
must as a group cover a range of systems, and must be
the same for a group of people followed serially (Searle
2008). An increasing number of deficits raise the likeli-
hood of being frail. It is expressed as the ratio of actual
number of deficits to total possible number of deficits
and is therefore a scalar measure ranging from 0 to 1.
Besides these two instruments, the FRAIL tool was
developed to identify older persons who are at risk for
frailty. It consists of five self-reported items which are
fatigue, resistance, ambulation, illnesses, and loss of
weight. Presence of three or more items defines frailty
(Morley 2013; van Kan 2008). In addition, the Tilburg
Frailty Indicator (TFI) is based on an integral conceptual
model of frailty which explicitly recognizes its multidi-
mensional nature by defining losses in one of more of
physical, psychological, and social functioning domains
through its 15 items (Gobbens 2010a). It is scored from
0 to 15, with higher scores representing higher levels of
frailty (Gobbens 2010b). While CHS frailty phenotype
and FRAIL focus on the physical domain, FI and TFI
attempt to measure frailty across more than a single
domain.
Not surprisingly, all these four instruments predict
future adverse outcomes in older people reasonably
well (Fried 2001; Gobbens 2012; Rockwood 2007a;
van Kan 2008). Moreover, where head-to-head com-
parisons are available, their predictive performance
was shown to be approximately equivalent
(Ravindrarajah 2013; Woo 2012). Past debate on
which instrument is best among them appears to have
run out its course over recent years and may now be
less relevant in moving frailty research and public
policy agendas forward. Rather, there is a growing
sense that different instruments are best suited for
different purposes (Cesari 2014; Martin 2008).
Mapping of different frailty instruments to specific
roles such as clinical screening, population studies, and
biomedical research has been proposed (Bouillon 2013;
Cesari 2014; Morley 2013). However, less work has
been done in developing suitable specifications for in-
vestigating frailty pathways which represent relation-
ships between frailty and its multidimensional predic-
tors and effects. The working framework proposed by
the Canadian Initiative on Frailty and Aging Frailty
provides an excellent reference for this endeavor and is
illustrated in Fig. 1. It conceptualizes frailty as having
seven components including five items of the Frailty
Phenotype and two additional items, namely, depression
and impaired cognition (Bergman 2004). However, both
depression and impaired cognition are psychological
factors that could very well be represented as predictors
and effects of frailty on its pathways. Having these as
components of the frailty specification and at the same
time as predictors or effects renders the task of teasing
out their relationship with frailty very challenging.More
recently, the integral concept of frailty proposed by
Gobbens built on the Canadian framework. Here, frailty
is explicitly specified as having separate physical, psy-
chological, and social domains (Gobbens 2010a). Doing
so allows physical frailty to be disaggregated from the
other two frailty domains and in turn facilitates less
constrained exploration of the relationship of frailty with
multidimensional antecedents and effects. The adoption
of this latter approach holds promise for developing
frailty specifications that can be usefully applied when
investigating relationships on these frailty pathways.
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In developing candidate physical frailty specifica-
tions for investigating frailty pathways, the CHS frailty
phenotype provides a good starting point particularly as
it is widely considered the prototype for physical frailty.
Its conceptual framework is represented by the cycle of
frailty in which its five components are positioned in a
set of pathways (Xue 2008) as illustrated in Fig. 2. In
this framework, sarcopenia holds a key position in the
cycle of frailty in the sense that it is on the main pathway
loop that includes weight loss, decreased total energy
expenditure, and chronic undernutrition. Moreover,
pathways emanating from it eventually lead to important
health-related endpoints, namely, impaired balance, falls
and injuries, immobilization, disabili ty, and
Fig. 1 Working framework proposed by the Canadian Initiative on Frailty and Aging Frailty (adapted from Bergman 2004 with
modifications)
Fig. 2 Modified representation
of the cycle of frailty (adapted
from Xue 2008)
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dependency. In these pathways to adverse outcomes,
weakness and exhaustion are positioned immediate-
ly downstream to sarcopenia and slowness immedi-
ately follows weakness. Given this framework, it
may be argued that among the five components of
the CHS frailty phenotype, the cluster of exhaustion,
weakness, and slowness appears central to the phys-
ical frailty concept and closest in proximity to its
adverse outcomes. In addition, two of these five
components pose interesting challenges. First, low
physical activity is considered a predictor of frailty
while its counter, exercise, is a modifier of frailty’s
effect (Daniels 2008; Strawbridge 1998). On this
account, it might be best excluded from the set of
physical frailty indicators. Indeed, Buchman used
the remaining four items to construct a composite
measure of physical frailty albeit using body mass
index instead of weight loss (Buchman 2009). Sec-
ond, exhaustion may at times be a manifestation of
depression in older people. In fact, two out of eight
items of the Center for Epidemiologic Studies De-
pression (CES-D) scale were used to operationalize
the component of exhaustion in the original study on
the CHS frailty phenotype (Fried 2001). Moreover,
depression resides within the psychological dimen-
sion and could itself be a potential target for inter-
ventions to reduce frailty and its effects. However,
given that exhaustion is more typically related to
physical conditions, it is unclear whether dropping
it from the set of frailty indicators is necessary. With
these points in mind, candidate physical frailty spec-
ifications based on the CHS frailty phenotype could
omit physical inactivity and possibly exhaustion,
thereby retaining three or four of the five original
indicators.
Over this backdrop, the aims of this study are
twofold. The first is to develop physical frailty spec-
ifications that are suitable for investigation of frailty
pathways. These will be based on three or four com-
ponents of the CHS frailty phenotype. The second is
to evaluate and compare candidate specifications on
their convergent, discriminant, and concurrent valid-
ity. The ultimate purpose is to obtain a frailty specifi-
cation that can be used to quantify the relationships of
frailty with its multidimensional predictors and ef-
fects. Ultimately, knowledge on these elements can
inform broad strategies employing population-level
interventions that seek to reduce frailty and its ad-
verse effects in older people.
Methods
Data
Panel data from wave 2 (2004) of the English Longitu-
dinal Study of Aging (ELSA) provides the requisite
information. This is a longitudinal survey of a represen-
tative sample of the English population aged 50 years
and older living in their homes at baseline (Steptoe
2013a). ELSA respondents aged 65 to 89 years at wave
2 are included. Those aged 90 years and older have their
age merely coded as B90^ and are thus excluded. All
participants gave informed consent. Ethical approval for
ELSA was granted by the Multicenter Research and
Ethics Committee. Ethical oversight for this study is
provided by procedures of the London School of Eco-
nomics Ethics Policy.
Measures
Indicators for physical frailty are based on four compo-
nents of the CHS frailty phenotype (Fried 2001). Slow-
ness is the average gait speed (m/s) of two attempts at
walking a distance of 2.4 m multiplied by −1. Weakness
is the dominant hand grip strength in kilograms multi-
plied by −1 for male and by −1.5 for female participants.
The difference in expectation of grip strength mirrors
population-independent cutoff values proposed for the
CHS frailty phenotype criteria (Saum 2012). Weight
loss is a binary variable for decrease in weight of more
than 5 kg from wave 0 to 2. Weight at wave 0 is used as
the reference because this was not measured at wave 1.
Exhaustion is also a binary variable based on a positive
reply to either or both of two items of the CES-D scale
on whether the respondent Bfelt everything they did
during the past week was an effort^ and Bcould not get
going much of the time in the past week^ (Radloff
1977).
Using three permutations of these indicators, candi-
date physical frailty specifications are developed. The
first specification has all four indicators, namely, slow-
ness, weakness, exhaustion, and weight loss. Using
latent class analysis of the CHS frailty phenotype, esti-
mated probabilities of individual components for frail
and non-frail states suggest that slowness and weakness
discriminated best between them (Bandeen-Roche
2006). Thus, these two indicators are retained for re-
maining specifications. The second specification drops
weight loss leaving the other three indicators. For the
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third, exhaustion instead of weight loss is dropped in
view of the potential concerns already alluded to.
For psychological frailty, three indicators adapted
from the TFI are constructed. First, impaired cognition
is based on total cognitive index which combines test
scores for memory and executive function which are
recoded (0 to 49) so that higher scores indicate poorer
function. Second, depressive symptoms are measured
by a number of positive items in the CES-D scale. Given
that the physical frailty indicator of exhaustion is based
on two of its eight items, only the remaining six are
used. Third, low resilience is measured in relation to
three facets of adversity previously proposed
(Demakakos 2008). Objective financial adversity is de-
fined as being in the lowest quintile of total non-pension
wealth. Self-perceived financial adversity is the report of
sometimes or more often having too little money to
spend on needs. Widowhood is the change of marital
status from being married or single in wave 1 to being
widowed in wave 2. The criterion for establishing resil-
ience under these three facets of adversity is a CES-D
score of three or less. Each facet is scored in an ordinal
manner with B−1^ if both adversity and resilience
criteria are satisfied, B1^ if only the criterion for adver-
sity is satisfied, and B0^ if only the criterion for resil-
ience is satisfied or if neither criterion is satisfied. Sum-
ming up those for the three facets, a total score ranging
from −3 to 3 is obtained where higher scores indicate
lower resilience.
For social frailty, three indicators adapted from the
TFI and based on previous work on social isolation
(Steptoe 2013b) are constructed. First, loneliness is
measured by the Revised UCLA Loneliness Score
which comprises three items and scored from 3 to 9
(Hughes 2004). Second, poor social integration is a
combination of five items (scored 0 to 15) on whether
participants have no spouse and partner living with
them, had little contact with children, had little contact
with other family members, had little contact with
friends, and were not a member of any organization,
club, or society. Little contact was defined as less than
monthly contact by meeting, phoning, or writing or e-
mail. Third, poor social support is the combined score
on three items (score 0 to 54) on whether there is lack of
positive support, and occurrence of negative support.
Lack of positive support is measured by positive an-
swers to questions on whether children, other family
members, and friends Bcriticizes the respondent,^ Blets
the respondent down,^ and Bgets on the nerves of
respondent.^ Negative support is measured by negative
answers to questions on Bunderstand the way you feel,^
Bcan rely on if you had a serious problem,^ and Bcan
open up to them if you need to talk^ with respect to
children, other family members, and friends.
The FI (Rockwood 2007b; Rockwood 2004) is com-
puted as the number of positive items out of 30 illnesses
and functional impairments divided by 30 thereby de-
riving a scalar value of 0 to 1 (Searle 2008). In line with
previously proposed cutoff values, people with FI of
0.08 or less are categorized as not frail, those with FI
of 0.25 or more are frail, and the remaining are pre-frail
(Song 2010).
Statistical analyses
Confirmatory factor analysis (CFA) is performed in turn
for the three candidate physical frailty specifications.
Unique factor scores for each participant are derived
for each specification. CFA is then repeated for sub-
groups defined by gender. Construct validity is assessed
by considering convergent and discriminant validity.
For convergent validity, functional impairment (number
of basic activities of daily living (BADL) and instru-
mental activities of daily living (IADL) performed with
difficulty), comorbidity (number of chronic illnesses),
and poor self-rated health are regressed in turn on phys-
ical frailty factor scores (Rockwood 2005). Coefficients
of the latter adjusting for age are obtained. For discrim-
inant validity, Pearson’s coefficient is used to quantify
the correlation of physical frailty factor scores with
those of psychological and social frailty factors. Factor
scores for the latter two are derived by CFA using their
respective indicators. Pearson’s coefficient higher than
0.90 indicates very high correlation, 0.71 to 0.90 indi-
cates high correlation, 0.51 to 0.70 indicates moderate
correlation, 0.31 to 0.50 indicates low correlation, and
0.30 indicates negligible correlation (Hinkle 2003). To
assess concurrent validity, FI is regressed on physical
frailty factor scores and their coefficients adjusting for
age are examined. For all validity checks, analyses are
performed for the whole group and then in subgroups
defined by gender.
CFA is performed withMplus version 7.4 (Muthén&
Muthén, 1998-2010) usingmaximum likelihood estima-
tion with robust standard errors (MLR) which handles
missing values by implementing full information max-
imum likelihood (FIML). MLR is selected over weight-
ed least squares with mean and variance adjustment
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Table 1 Characteristics of English Longitudinal Study of Aging (ELSA) wave 2 respondents aged 65 to 89 years included for analyses
(N = 4638 for all, 2070 for male, and 2568 for female unless indicated otherwise)
Variables All By gender
Male Female
General:
Mean age, years (SD) 74.0 (6.3) 73.5 (6.2) 74.3 (6.4)
Female, n/N (%) 2568/4638 (55.4) – –
Mean chronic disease count (SD) 1.9 (1.4)1 1.8 (1.4)2 2.0 (1.4)3
Number of basic activities of daily living
(BADL) items with difficulty, n (%)
0 3389/4635 (73.1) 1560/2070 (75.4) 1829/2565 (71.3)
1 or 2 948/4635 (20.5) 389/2070 (18.8) 559/2565 (21.8)
3 or 4 220/4635 (4.8) 95/2070 (4.6) 125/2565 (4.9)
5 or 6 78/4635 (1.7) 26/2070 (1.3) 52/2565 (2.0)
Number of instrumental activities of daily living (IADL)
items with difficulty, n/N (%)
0 3308/4635 (71.4) 1593/2070 (77.0) 1715/2565 (66.9)
1 or 2 991/4635 (21.4) 358/2070 (17.3) 633/2565 (24.7)
3 or 4 236/4635 (5.1) 77/2070 (3.7) 159/2565 (6.2)
5 or 6 or 7 100/4635 (2.2) 42/2070 (2.0) 58/2565 (2.3)
Self-rated health, n/N (%)
Excellent or very good 1554/4565 (34.0) 674/2029 (33.2) 880/2536 (34.7)
Good 1528/4565 (33.5) 686/2029 (33.8) 842/2536 (33.2)
Fair or poor 1483/4565 (32.5) 669/2029 (33.0) 814/2536 (32.1)
Physical:
Mean average walking speed, m/s (SD) 0.82 (0.28)4 0.86 (0.27)5 0.78 (0.28)6
Hand grip strength (dominant hand), kg (SD) 25.9 (10.2)7 33.4 (8.9)8 19.6 (6.1)9
Exhaustion, n/N (%) 1490/4510 (33.0) 568/1997 (33.0) 992/25103(33.0)
Weight loss >5 kg from waves 0 to 2, n/N (%) 587/3590 (16.4) 255/1608 (15.9) 332/1982 (16.8)
Frailty status by modified CHS frailty phenotype, n/N (%)
Not frail 866/3242 (26.7) 485/1462 (33.2) 381/1780 (21.4)
Pre-frail 1758/3242 (54.2) 775/1462 (53.0) 983/1780 (55.2)
Frail 618/3242 (19.1) 202/1462 (13.8) 416/1780 (33.4)
Frailty status by Frailty Index a, n/N (%)
Not frail 1444/3647 (39.6) 774/1639 (47.2) 670/2008 (33.4)
Pre-frail 1486/3647 (40.8) 629/1639 (38.4) 857/2008 (42.7)
Frail 717/3647 (20.7) 236/1639 (24.4) 481/2008 (33.9)
Psychological:
Mean cognitive impairment score (SD) 18.9 (6.5)10 19.3 (6.4)11 18.5 (6.5)12
Mean CESD-8 c score (SD) 1.7 (2.0)13 1.3 (1.7)14 1.9 (2.1)15
Mean low resilience score d (SD) 0.20 (0.83)16 0.13 (0.80)17 0.26 (0.84)18
Social:
Loneliness score e (SD) 4.2 (1.5)19 4.0 (1.4)20 4.3 (1.6)21
Mean poor social support score f (SD) 13.7 (7.0)22 14.7 (7.0)23 12.9 (6.8)24
Mean poor social integration score g (SD) 6.6 (2.5)25 6.7 (2.6)26 6.5 (2.5)27
Outcome:
2-year mortality, n/N (%) 278/4638 (6.0) 147/2070 (7.1) 131/2568 (5.1)
n = 1 4608, 2 2052, 3 2556, 4 4092, 5 1826, 6 2266, 7 3869, 8 1760, 9 2109, 10 4348, 11 1945, 12 2403, 13 4479, 14 1987, 15 2492, 16 3854,
17 1946, 18 2460, 19 3854, 20 1746, 21 2106, 22 3339, 23 1529, 24 1810, 25 3267, 26 1506, and 27 1761
a Frailty Index: 30 items (score 0 to 1)
b Cognitive impairment score: score 0 to 49
c CESD-8: Center for Epidemiologic Studies Depression Scale - 8 items (score 0 to 8)
d Low resilience score: 3 items (score 3 to 12)
e Loneliness score: Revised UCLA Loneliness Score - 3 items (score 3 to 9)
f Low social support score: 18 items (score 0 to 54)
g Poor social integration score: 6 items (score 0 to 15)
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(WLSMV) because of better handling ofmissing values.
For other regression analyses, missing values are han-
dled by multiple imputation using chained equations to
generate 20 sets. In using FIML and multiple imputa-
tion, the assumption of missing at random (MAR) is
held. All other data analyses are performed with Stata
version 13.1. Statistical significance is taken at p value
of less than 0.05.
Results
Data of 4638 people (2070 male and 2568 female) aged
from 65 to 89 years are analyzed. Their characteristics
are summarized in Table 1. They have on average two
chronic illnesses. More than one quarter of them have
some degree of functional impairment measured by
basic activities of daily living. As expected, physical
performance measured by walking speed and hand grip
strength is worse among female participants. Frailty
measured by both modified CHS frailty phenotype and
Frailty Index is more common among them too. Thus, a
significant proportion of participants have health issues
and functional limitations. Among psychological mea-
sures, female participants display less resilience. Some-
what surprisingly, there are only minimal differences in
social measures across gender.
Table 2 summarizes the results of CFA for the three
physical frailty specifications. For four indicators, slow-
ness contributes most to the physical frailty factor
whereas weakness and exhaustion do so to a lesser
extent. Weight loss contributes much less. Similarly
for three indicators including exhaustion, slowness con-
tributes more than weakness and exhaustion do. On the
other hand, for three indicators including weight loss,
weakness contributes most with slowness doing so less.
Here again, weight loss contributes minimally. These
patterns are generally consistent across gender with only
minor differences seen. These factor loading patterns
reflect the stronger correlation among slowness, weak-
ness, and exhaustion, compared with their correlation
with weight loss. These differences in correlation are
supported by tetrachoric correlation coefficients of
weight loss with the other three indicators (0.16 to
0.19) being much lower than those between the other
three (0.29 to 0.43) for the whole group as shown in
Table S6 of the Supplementary Materials. Histograms
showing approximately normal distribution of derived
factor scores for the three physical frailty specifications
are provided in Fig. S3 of the Supplementary Materials.
In terms of convergent validity, Table 3 shows that
for 1 standard deviation (SD) increase in the physical
frailty factor score, the number of chronic diseases in-
creases by 0.28 to 0.35 across specifications and gender
after adjusting for age. Similarly, for 1 SD increase in
physical frailty factor score, the combined number of
items of BADL and IADL performed with difficulty
increases by 0.36 to 0.51. Finally, for 1 SD increase in
physical frailty factor score, the number of categories of
poor self-rated health increases by 0.38 to 0.54. Regres-
sion coefficients are of similar magnitude across gender
with the exception of the specification with three indi-
cators including weight loss where they are clearly
Table 2 Measurement model for three specifications of physical
frailty and using confirmatory factor analysis (CFA) using full
information maximum likelihood (FIML) [N = 4547 (all), 2019
(male), and 2528 (female) for the first two specifications;N = 4440








Slowness a 0.76 (0.03) 0.73 (0.05) 0.77 (0.03)
Weakness b 0.54 (0.02) 0.47 (0.04) 0.56 (0.03)
Exhaustion c 0.55 (0.02) 0.56 (0.04) 0.54 (0.03)
Weight loss d 0.28 (0.03) 0.24 (0.06) 0.31 (0.04)
Three indicators including exhaustion:
Slowness a 0.78 (0.03) 0.79 (0.05) 0.78 (0.04)
Weakness b 0.52 (0.02) 0.79 (0.05) 0.55 (0.03)
Exhaustion c 0.54 (0.03) 0.53 (0.04) 0.54 (0.03)
Three indicators including weight loss:
Slowness a 0.60 (0.05) 0.45 (0.08) 0.68 (0.06)
Weakness b 0.68 (0.05) 0.76 (0.13) 0.63 (0.06)
Weight loss d 0.30 (0.03) 0.26 (0.06) 0.33 (0.04)
p values are <0.05 for all coefficients
a Slowness: mean gait speed multiplied by a factor of −1
bWeakness: dominant hand grip strength multiplied by a factor of
−1 (males) or −1.5 (females)
c Exhaustion: positive response to either or both of two items of
CES-D scale on Bcould not get going much of the time in the past
week^ and Bfelt everything they did during the past week was an
effort^
dWeight loss: decrease in weight of more than 5 kg fromwave 0 to
wave 2
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higher for female participants. Overall, regression coef-
ficients for physical frailty factor scores with four indi-
cators and with three indicators including exhaustion are
very similar. However, their coefficients are higher than
those with three indicators including weight loss, partic-
ularly for prediction of BADL and ADL difficulties, as
well as poor self-rated health where there is minimal or
no overlap of confidence intervals. The likely explana-
tion is that as individual indicators, slowness, weakness,
and exhaustion predict these outcomes better than
weight loss does. This is supported by the results of
linear regression analyses shown in Table S7 of the
Supplementary Materials which show that slowness
and exhaustion predict these three outcomes best,
followed distantly by weakness, and finally weight loss.
Notably, Akaike information criterion (AIC) and Bayes-
ian information criterion (BIC) values for models with
the first two specifications are similar while those with
the third specification are higher (see footnote of
Table 3). This means that the goodness of fit of models
with the first two specifications are similar but better
than those with the third specification. In addition, r-
square values and, therefore, the variance explained for
models with the first two specifications are also very
similar but higher than those with the third specification
(see footnote of Table 3). Overall, these findings indi-
cate that the first two physical frailty specifications have
higher convergent validity than the third.
For discriminant validity, Table 4 shows that physical
frailty factor scores for the first two specifications have
low correlation with psychological frailty and negligible
correlation with social frailty. In contrast, physical frail-
ty factor score for the third specification has negligible
correlation with the other frailty domains, suggesting
higher discriminant validity. Nevertheless, all Pearson’s
coefficients are well below the arbitrary 0.85 cutoff level
where greater values are regarded as indicating low
discriminant validity. Equally important, the correlation
Table 3 Linear regression of chronic disease, functional status, and self-rated health on factor scores for three physical frailty specifications
adjusted for age: standardized coefficients (95 % confidence interval) (N = 4638 for all, 2070 for male, and 2568 for female)
All By gender
Male Female
Number of chronic diseases:
4 indicators 0.35 (0.32 to 0.38)a 0.34 (0.29 to 0.38) 0.34 (0.30 to 0.39)
3 indicators (including exhaustion) 0.34 (0.31 to 0.37)b 0.33 (0.29 to 0.38) 0.34 (0.30 to 0.38)
3 indicators (including weight loss) 0.30 (0.27 to 0.33)c 0.28 (0.23 to 0.33) 0.29 (0.25 to 0.34)
Number of basic and instrumental activities of daily living items performed with difficulty:
4 indicators 0.49 (0.46 to 0.52)d 0.46 (0.42 to 0.50) 0.51 (0.47 to 0.55)
3 indicators (including exhaustion) 0.48 (0.46 to 0.51)e 0.45 (0.41 to 0.50) 0.50 (0.46 to 0.54)
3 indicators (including weight loss) 0.39 (0.36 to 0.43)f 0.36 (0.31 to 0.41) 0.41 (0.37 to 0.45)
Categories of poor self-rated health:
4 indicators 0.51 (0.48 to 0.53)g 0.48 (0.43 to 0.52) 0.54 (0.51 to 0.58)
3 indicators (including exhaustion) 0.50 (0.47 to 0.53)h 0.47 (0.43 to 0.51) 0.53 (0.50 to 0.57)
3 indicators (including weight loss) 0.40 (0.37 to 0.43)i 0.38 (0.33 to 0.43) 0.44 (0.40 to 0.48)
p values are <0.05 for all coefficients
a AIC/BIC = 15,902/15,922, r2 = 0.12
bAIC/BIC = 15,917/15,935, r2 = 0.12
c AIC/BIC = 16,071/16,090, r2 = 0.09
dAIC/BIC = 18,572/18,591, r2 = 0.25
e AIC/BIC = 18,600/18,620, r2 = 0.25
f AIC/BIC = 19,048/19,067, r2 = 0.17
gAIC/BIC = 13,018/13,038, r2 = 0.23
hAIC/BIC = 13,047/13,066, r2 = 0.22
i AIC/BIC = 13,483/13,503, r2 = 0.14
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coefficients between the three different physical frailty
specifications (multimethod) are in the region of 0.88 to
1.00 and therefore much larger than those between
physical frailty and psychological frailty or social frailty
(multitrait) which are from 0.12 to 0.41. This further
supports discriminant validity. The corresponding
Table 4 Correlation of factor scores for three physical frailty
specifications with those for psychological and social frailty, and
between factor scores for three physical frailty specifications
(modified multitrait multimethod analysis): Pearson’s coefficient
(95 % confidence interval) (N = 4638 for all, 2070 for male, and
2568 for female)
Pearson’s correlation coefficient (Standard error)
All By gender
Male Female
Between physical and psychological frailty:
4 indicators 0.41 0.38 0.40
(0.38 to 0.43) (0.34 to 0.42) (0.36 to 0.43)
3 indicators (including exhaustion) 0.40 0.38 0.39
(0.37 to 0.43) (0.34 to 0.42) (0.35 to 0.43)
3 indicators (including weight loss) 0.29 0.26 0.28
(0.26 to 0.32) (0.22 to 0.30) (0.24 to 0.32)
Between physical and social frailty:
4 indicators 0.16 0.18 0.17
(0.13 to 0.20) (0.14 to 0.23) (0.12 to 0.22)
3 indicators (including exhaustion) 0.16 0.18 0.17
(0.13 to 0.19) (0.13 to 0.23) (0.12 to 0.21)
3 indicators (including weight loss) 0.12 0.13 0.14
(0.08 to 0.15) (0.08 to 0.18) (0.09 to 0.18)
Between specifications of physical frailty:
3 indicators (including exhaustion) and 3 indicators (including weight loss) 0.89 0.88 0.89
(0.87 to 0.90) (0.86 to 0.90) (0.87 to 0.90)
4 indicators and 3 indicators (including exhaustion) 1.00 1.00 1.00
(0.99 to 1.00) (0.99 to 1.00) (0.99 to 1.00)
3 indicators (including weight loss) and 4 indicators 0.90 0.90 0.90
(0.89 to 0.91) (0.88 to 0.91) (0.89 to 0.92)
p values are <0.05 for all correlation coefficients
Table 5 Linear regression of Frailty Index on factor scores for three physical frailty specifications adjusted for age with multiple imputation:
standardized coefficients (N = 4638 for all, 2070 for male, and 2568 for female)
All By gender
Male Female
4 indicators 0.76 (0.73 to 0.79) a 0.76 (0.71 to 0.80) 0.76 (0.72 to 0.79)
3 indicators (including exhaustion) 0.75 (0.72 to 0.78) b 0.74 (0.70 to 0.79) 0.74 (0.71 to 0.78)
3 indicators (including weight loss) 0.62 (0.59 to 0.65) c 0.61 (0.55 to 0.66) 0.61 (0.57 to 0.65)
p values are <0.05 for all physical frailty factor scores coefficients
a AIC/BIC = −6998/−6978, r2 = 0.44
bAIC/BIC = −6918/−6899, r2 = 0.43
c AIC/BIC = −5977/−5957, r2 = 0.30
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Modified Multitrait Multimethod (MTMM) Matrix is
provided in Table S8 of the Supplementary Materials.
Where concurrent validity is concerned, multiple
linear regression analyses obtained statistically signifi-
cant coefficients for all three physical frailty specifica-
tions as shown in Table 5. For 1 SD increase in physical
frailty factor scores, the FI increases by 0.61 to 0.76 SD.
There are minor variations of regression coefficients
across gender. Overall, regression coefficients are higher
for specifications with four indicators and with three
indicators including exhaustion than those for the third
specification. Yet again, AIC and BIC values for models
with the first two specifications are similar while those
with the third specification are higher. R-square values
are almost equivalent for the first two specifications and
higher than those of the third (see footnote of Table 5).
This means that the goodness of fit of models and
variance explained by models with the first two specifi-
cations are similar but better or higher than those with
the third specification. Together, these findings indicate
that concurrent validity for the first two specifications is
higher than that for the third.
As sensitivity analysis, the CFA for physical frailty
and regressions for evaluating convergent and concur-
rent validity are repeated using the WLSMV estimator.
Comparison of coefficients obtained using MLR and
WLSMVestimators is provided in Tables S9, S10, and
S11 in the Supplementary Materials. Overall, only triv-
ial differences are observed in the coefficients which do
not change the interpretation of the results.
Discussion
This study reports the development of frailty specifica-
tions for the purpose of investigating multidimensional
predictors and effects of frailty such as those proposed
by the working framework of the Canadian Initiative on
Frailty and Aging. Rather than adopting a broad defini-
tion, narrower focus on physical frailty is employed to
enhance prospective application when investigating its
relationship with multidimensional elements on frailty
pathways. In addition, physical frailty is viewed as a
construct and is thus developed as a factor. Unlike the
case with established frailty instruments including the
CHS frailty phenotype where contribution of separate
components is arbitrarily assumed and then fixed, latent
variable analysis through CFA is performed to empiri-
cally derive the relationship of each indicator with the
physical frailty factor. Furthermore, CFA allows mea-
surement error to be accounted for, which is particularly
relevant as performance measures are used as indicators.
This combined approach represents an advance on the
frailty specification proposed in the working framework
of the Canadian Initiative on Frailty and Aging and
further builds on that put forth in the integral concept
of frailty (Bergman 2004; Gobbens 2010a).
To begin with, content validity is retained to a large
extent given that the selected indicators used are
drawn from the original components of the CHS frail-
ty phenotype which is still widely regarded as the
prototype of physical frailty. Higher weightage is
accorded to slowness, weakness, and exhaustion giv-
en the relative importance of their positions in the
cycle of frailty. Thus, the physical frailty specification
with three indicators including exhaustion could be
considered as having the essential set of indicators.
Furthermore, for candidate specifications examined,
slowness is central to the physical frailty factor except
for the case with three indicators including weight
loss. Weight loss clearly contributes little and an ar-
gument may be made for its exclusion as an indicator
at least on the basis of the findings from this study. It
is notable that our results are generally consistent
across gender. More crucially, higher convergent and
concurrent validity with four indicators and with three
indicators including exhaustion are demonstrated
over the third specification. Although the latter per-
forms better on discriminant validity, the first two
specifications have sufficiently low correlation with
psychological and social frailty to suggest that over-
lap of their constructs is probably not large enough to
be of practical concern. This is important when ex-
amining the relationship of physical frailty with mul-
tidimensional elements including those which are
closely related to or are themselves deployed as indi-
cators of psychological and social frailty.
Given these findings, physical frailty specifications
with four indicators and that with three indicators in-
cluding exhaustion appear to be suitable candidates for
use in investigation of frailty pathways. Minimal contri-
bution of weight loss as the fourth indicator suggests
that three indicators, namely, slowness, weakness, and
fatigue may be sufficient to represent physical frailty.
However, the performance of these physical frailty spec-
ifications in predicting adverse health-related outcomes
needs to be separately evaluated. This is an issue that is
addressed in further research.
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Although encouraging, these findings should to be
viewed in the context of the study limitations. First, data
from only one population is used and, therefore, there is
uncertainty on the extent to which these findings may be
generalized to other populations. To address this issue,
the measurement model from this study needs to be
applied to data from other populations in future work.
Next, secondary data is used. The consequence is that
choice of variables representing physical frailty is inevi-
tably restricted. Nevertheless, selected variables arguably
have face validity. The major challenge is the quantifica-
tion of weight loss which is by necessity across the span
of 4 years due to weight measurements not being avail-
able in wave 1. It remains to be seen whether weight loss
may perform better as an indicator when change is mea-
sured across a shorter period of time such as 2 years.
Third, missing data may introduce bias in our analyses.
Multiple imputation is used to handle this issue here and
requires the missing at random (MAR) assumption. Not-
withstanding the inevitable uncertainty on the extent of
bias introduced, this is not likely to be large enough to
change the conclusions on the validity of physical frailty
specifications evaluated here.
On the other hand, the strengths of this study include
the use of ELSAwhich offers representative, reliable, and
high-quality data that has produced a wealth of informa-
tion on how older people age in England. Moreover, our
relatively large sample size allows greater precision in
estimation. Lastly, availability of physical performance
measures for two physical frailty indicators providesmore
detailed information than questionnaire data alone would.
In conclusion, narrowing of the frailty specification
to that of physical frailty is argued on the grounds that
multidimensional elements on frailty pathways are best
excluded from the set of its indicators. Suitable indica-
tors are drawn from components of the CHS frailty
phenotype and include slowness, weakness, and exhaus-
tion with or without weight loss. In addition to retaining
face and content validity, these two physical frailty
specifications have demonstrated reasonable conver-
gent, discriminatory, and concurrent validity using the
data of older people living in England. Together, they
hold promise as physical frailty specifications to be
applied in the investigation of frailty pathways.
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